-
Vera Therapeutics (NASDAQ:VERA) priced an underwritten public offering of 7,142,858 shares at a price to the public of $42.00 per share.
-
The gross proceeds are expected to be approximately $300M.
-
Underwriters have a 30-day option to purchase up to an additional ~1.07M shares.
-
The offering is expected to close on October 31, 2024.
Vera Therapeutics prices $300M offering at $42 per share (NASDAQ:VERA)
BlackSky announces proposed public offering of common stock
